Loss of ASS1 expression has been associated with poor prognosis in bladder cancer and glioblastoma4,8 and recent data indicate that ASS1 downregulation supports cancer growth allowing aspartate channeling into pyrimidine biosynthesis36. Here, ASS1 is linked to urinary bladder cancer.